Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

1.84
Delayed Data
As of Feb 05
 -0.01 / -0.54%
Today’s Change
1.40
Today|||52-Week Range
8.46
-36.11%
Year-to-Date

Today’s Trading

Previous close1.85
Today’s open1.84
Day’s range1.76 - 1.85
Volume209,324
Average volume (3 months)500,693
Market cap$36.6M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-128.57%
Earnings growth (this year)+3.97%
Earnings growth (next 5 years)+74.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.86

Competitors

 Today’s
change
Today’s
% change
CBLICleveland Biolabs In...-0.16-4.48%
NVETNexvet Biopharma plc-0.22-6.51%
STDYSteadymed Ltd+0.20+8.30%
OGENOragenics Inc-0.02-2.08%
Data as of 3:59pm ET, 02/05/2016

Financials

Next reporting dateMarch 24, 2016
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$0.00
Annual profit (last year)-$22.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Steven J. Mento
Chief Financial Officer, Secretary &
SVP
Charles J. Cashion
Corporate headquarters
San Diego, California

Forecasts

Partner Offers